The side effects of platinum-based chemotherapy drugs: a review for chemists

Cisplatin induced arrhythmia; electrolyte imbalance or disturbance of the SA node?

(2017) Rabbab Oun et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

(2017) Paul J. Hesketh et al.   JOURNAL OF CLINICAL ONCOLOGY

Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

(2017) Jeffrey Crawford et al.   Journal of the National Comprehensive Cancer Network

Ototoxicity and cancer therapy

(2016) Wendy Landier   CANCER

Myelosuppression by chemotherapy in obese patients with gynecological cancers

(2016) Kensuke Kamimura et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies

(2016) Karel Ulbrich et al.   CHEMICAL REVIEWS

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

(2016) Timothy C. Johnstone et al.   CHEMICAL REVIEWS

How to assess the role of Pt and Zn in the nephrotoxicity of Pt anti-cancer drugs? An investigation combining μXRF and statistical analysis: Part I: On mice

(2016) Emmanuel Estève et al.   COMPTES RENDUS CHIMIE

Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients

(2016) F. Tixier et al.   HEMATOLOGICAL ONCOLOGY

Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan

(2016) Kazuo Tamura et al.   International Journal of Clinical Oncology

Cisplatin resistance and opportunities for precision medicine

(2016) Lauren Amable   PHARMACOLOGICAL RESEARCH

Bradycardia as a rare symptom of cisplatin cardiotoxicity: A case report

(2016) JAKUB KUCHARZ et al.   Oncology Letters

Infliximab Modulates Cisplatin-Induced Hepatotoxicity in Rats

(2016) Medine Cumhur Cure et al.   Balkan Medical Journal

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas

(2016) Jantien Hoek et al.   Cancers

Cisplatin binding to human serum albumin: a structural study

(2015) Giarita Ferraro et al.   CHEMICAL COMMUNICATIONS

Platinum(II) as Bifunctional Linker in Antibody-Drug Conjugate Formation: Coupling of a 4-Nitrobenzo-2-oxa-1,3-diazole Fluorophore to Trastuzumab as a Model

(2015) Dennis C. J. Waalboer et al.   ChemMedChem

Aptamers in Targeted Nanotherapy

(2015) Anila Mathew et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Cisplatin hepatotoxicity mediated by mitochondrial stress

(2015) Mohammad Waseem et al.   DRUG AND CHEMICAL TOXICOLOGY

Cisplatin induced bradycardia

(2015) H.S. Darling   INTERNATIONAL JOURNAL OF CARDIOLOGY

Oxaliplatin-induced neurotoxicity is mediated through gap junction channels and hemichannels and can be prevented by octanol

(2015) Alexia Kagiava et al.   NEUROPHARMACOLOGY

Investigation of antibacterial and biofilm inhibition activity of Michelia figo leaf extracts against dental bacterium

(2015) X Song et al.   PLANTA MEDICA

Cardiotoxicity: Cisplatin and long-term cancer survivors

(2014) Salvatore Patanè   INTERNATIONAL JOURNAL OF CARDIOLOGY

Nanocarriers for delivery of platinum anticancer drugs

(2013) Hardeep S. Oberoi et al.   ADVANCED DRUG DELIVERY REVIEWS

Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals

(2013) Zheng Dong Liang et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2

(2013) J. A. Sprowl et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer

(2012) Robin A. Laskey et al.   GYNECOLOGIC ONCOLOGY

Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells

(2012) Ganna V. Kalayda et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Oxaliplatin: a review of approved uses

(2011) Alexander Stein et al.   EXPERT OPINION ON PHARMACOTHERAPY

Nephrotoxicity of platinum derivatives in children – a review of the literature

(2011) Joanna Stefanowicz et al.   Wspolczesna Onkologia-Contemporary Oncology

Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies

(2010) El-Sayed E. El-Awady et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Mechanisms of Cisplatin Nephrotoxicity

(2010) Ronald P. Miller et al.   Toxins

Chemotherapy-Associated Hepatotoxicity: Do We Need to Be Concerned?

(2009) Michael A. Choti   ANNALS OF SURGICAL ONCOLOGY

Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy

(2009) Susanna B. Park et al.   BRAIN

Cisplatin Overdose

(2009) Roger Y. Tsang et al.   DRUG SAFETY

Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases

(2009) Yun Shin Chun et al.   LANCET ONCOLOGY

Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients

(2009) D Caronia et al.   PHARMACOGENOMICS JOURNAL

Cisplatin Ototoxicity and Protection: Clinical and Experimental Studies

(2009) Leonard P Rybak et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care

(2008) Vincent Launay-Vacher et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Targeted Single-Wall Carbon Nanotube-Mediated Pt(IV) Prodrug Delivery Using Folate as a Homing Device

(2008) Shanta Dhar et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma

(2008) Nadia Barahmani et al.   NEURO-ONCOLOGY

Cisplatin: a review of toxicities and therapeutic applications

(2008) K. Barabas et al.   Veterinary and Comparative Oncology